Electra Therapeutics is a Biotech company. It has raised $84M in total funding. Latest round: Series B. Backed by OrbiMed, Westlake Village BioPartners.
Electra Therapeutics is a Biotech company. Electra Therapeutics has raised $84M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in October 2025. The round record for Electra Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include OrbiMed, Westlake Village BioPartners. 2 distinct backers are named across the disclosed rounds.
Electra Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026